Loading…
Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets
MicroRNAs (miRNAs) are small, single-stranded, endogenous non-coding RNAs that repress the expression of target genes via post-transcriptional mechanisms. Due to their broad regulatory effects, the precisely regulated, spatial-specific and temporal-specific expression of miRNAs is fundamentally impo...
Saved in:
Published in: | Cancer letters 2018-08, Vol.428, p.90-103 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c456t-592398da7f01b1c89d2e80e3abab148608047d69e6c2f2b6b5577c75f07f1f2f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c456t-592398da7f01b1c89d2e80e3abab148608047d69e6c2f2b6b5577c75f07f1f2f3 |
container_end_page | 103 |
container_issue | |
container_start_page | 90 |
container_title | Cancer letters |
container_volume | 428 |
creator | Long, Hai Wang, Xin Chen, Yongjian Wang, Ling Zhao, Ming Lu, Qianjin |
description | MicroRNAs (miRNAs) are small, single-stranded, endogenous non-coding RNAs that repress the expression of target genes via post-transcriptional mechanisms. Due to their broad regulatory effects, the precisely regulated, spatial-specific and temporal-specific expression of miRNAs is fundamentally important to various biological processes including the immune homeostasis and normal function of both innate and adaptive immune response. Aberrance of miRNAs is implicated in the development of various human diseases, especially cancers. Increasing evidence has revealed a dysregulated expression pattern of miRNAs in autoimmune diseases, among which many play key roles in the pathogenesis. In this review we summarize these findings on miRNA dysregulation implicated in autoimmune diseases, focusing on four representative systemic autoimmune diseases, i.e. systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis and dermatomyositis. The causes of the dysregulation of miRNA expression in autoimmune diseases may include genetic and epigenetic variants, and various environmental factors. Further understanding of miRNA dysregulation and its mechanisms during the development of different autoimmune diseases holds enormous potential to bring about novel therapeutic targets or strategies for these complex human disorders, as well as novel circulating or exosomal miRNA biomarkers.
•miRNAs play crucial roles in regulating both innate and adaptive immune response.•miRNA dysregulation are implicated in the pathogenesis of many autoimmune diseases.•Genetic, epigenetic, and environmental factors affect miRNAs and cause autoimmunity.•miRNAs serve as potential therapeutic targets and biomarkers for autoimmune diseases.•Circulating miRNAs and exosomal miRNAs may be ideal novel biomarkers for SLE and RA. |
doi_str_mv | 10.1016/j.canlet.2018.04.016 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2029631819</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0304383518302775</els_id><sourcerecordid>2042689057</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-592398da7f01b1c89d2e80e3abab148608047d69e6c2f2b6b5577c75f07f1f2f3</originalsourceid><addsrcrecordid>eNp9kcFu1DAQhi1ERbeFN0DIEhcOJIydOHY4IFWlUKQKEIKz5TiTrZfE3toOUt8eV1t66IGTpdE3M57vJ-Qlg5oB697tamv8jLnmwFQNbV2KT8iGKckr2St4SjbQQFs1qhHH5CSlHQCIVopn5Jj3nQLOmw1ZPt6miNt1NtkFT8NEF2dj-PH1LFHnqVlzcMuyeqSjS2gSpvf0u8nXYYsek0tv6eDCYuJvjIkaP9J9yOizMzPN1xjNHtfsLM0mbjGn5-RoMnPCF_fvKfn16eLn-WV19e3zl_Ozq8q2osuV6HnTq9HICdjArOpHjgqwMYMZWKs6UNDKseuxs3ziQzcIIaWVYgI5sYlPzSl5c5i7j-FmxZT14pLFeTYew5o0h2KgYYr1BX39CN2FNfryu0K1vFM9CFmo9kAVN6kIm_Q-unL2rWag7-LQO32IQ9_FoaHVpVjaXt0PX4cFx4emf_4L8OEAYLHxx2HUyTr0FkcX0WY9Bvf_DX8BQEqebQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2042689057</pqid></control><display><type>article</type><title>Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets</title><source>ScienceDirect Freedom Collection</source><creator>Long, Hai ; Wang, Xin ; Chen, Yongjian ; Wang, Ling ; Zhao, Ming ; Lu, Qianjin</creator><creatorcontrib>Long, Hai ; Wang, Xin ; Chen, Yongjian ; Wang, Ling ; Zhao, Ming ; Lu, Qianjin</creatorcontrib><description>MicroRNAs (miRNAs) are small, single-stranded, endogenous non-coding RNAs that repress the expression of target genes via post-transcriptional mechanisms. Due to their broad regulatory effects, the precisely regulated, spatial-specific and temporal-specific expression of miRNAs is fundamentally important to various biological processes including the immune homeostasis and normal function of both innate and adaptive immune response. Aberrance of miRNAs is implicated in the development of various human diseases, especially cancers. Increasing evidence has revealed a dysregulated expression pattern of miRNAs in autoimmune diseases, among which many play key roles in the pathogenesis. In this review we summarize these findings on miRNA dysregulation implicated in autoimmune diseases, focusing on four representative systemic autoimmune diseases, i.e. systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis and dermatomyositis. The causes of the dysregulation of miRNA expression in autoimmune diseases may include genetic and epigenetic variants, and various environmental factors. Further understanding of miRNA dysregulation and its mechanisms during the development of different autoimmune diseases holds enormous potential to bring about novel therapeutic targets or strategies for these complex human disorders, as well as novel circulating or exosomal miRNA biomarkers.
•miRNAs play crucial roles in regulating both innate and adaptive immune response.•miRNA dysregulation are implicated in the pathogenesis of many autoimmune diseases.•Genetic, epigenetic, and environmental factors affect miRNAs and cause autoimmunity.•miRNAs serve as potential therapeutic targets and biomarkers for autoimmune diseases.•Circulating miRNAs and exosomal miRNAs may be ideal novel biomarkers for SLE and RA.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/j.canlet.2018.04.016</identifier><identifier>PMID: 29680223</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Adaptive immunity ; Apoptosis ; Autoimmune diseases ; Bioindicators ; Biomarkers ; Biopsy ; Chronic conditions ; Cyclin-dependent kinases ; Dermatomyositis ; Dermatomyositis (DM) ; Disease ; Environmental factors ; Epigenetic mechanisms ; Fibroblasts ; Gene expression ; Genomes ; Growth factors ; Homeostasis ; Immune response ; Immunity ; Inflammation ; Kinases ; Lupus ; Lymphocytes ; MicroRNAs ; miRNA ; Pathogenesis ; Post-transcription ; Proteins ; Rheumatoid arthritis ; Rheumatoid arthritis (RA) ; RNA polymerase ; Scleroderma ; Sclerosis ; Spatial discrimination ; Systemic lupus erythematosus ; Systemic lupus erythematosus (SLE) ; Systemic sclerosis ; Systemic sclerosis (SSc) ; Therapeutic applications</subject><ispartof>Cancer letters, 2018-08, Vol.428, p.90-103</ispartof><rights>2018 Elsevier B.V.</rights><rights>Copyright © 2018 Elsevier B.V. All rights reserved.</rights><rights>Copyright Elsevier Limited Aug 1, 2018</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-592398da7f01b1c89d2e80e3abab148608047d69e6c2f2b6b5577c75f07f1f2f3</citedby><cites>FETCH-LOGICAL-c456t-592398da7f01b1c89d2e80e3abab148608047d69e6c2f2b6b5577c75f07f1f2f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29680223$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Long, Hai</creatorcontrib><creatorcontrib>Wang, Xin</creatorcontrib><creatorcontrib>Chen, Yongjian</creatorcontrib><creatorcontrib>Wang, Ling</creatorcontrib><creatorcontrib>Zhao, Ming</creatorcontrib><creatorcontrib>Lu, Qianjin</creatorcontrib><title>Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>MicroRNAs (miRNAs) are small, single-stranded, endogenous non-coding RNAs that repress the expression of target genes via post-transcriptional mechanisms. Due to their broad regulatory effects, the precisely regulated, spatial-specific and temporal-specific expression of miRNAs is fundamentally important to various biological processes including the immune homeostasis and normal function of both innate and adaptive immune response. Aberrance of miRNAs is implicated in the development of various human diseases, especially cancers. Increasing evidence has revealed a dysregulated expression pattern of miRNAs in autoimmune diseases, among which many play key roles in the pathogenesis. In this review we summarize these findings on miRNA dysregulation implicated in autoimmune diseases, focusing on four representative systemic autoimmune diseases, i.e. systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis and dermatomyositis. The causes of the dysregulation of miRNA expression in autoimmune diseases may include genetic and epigenetic variants, and various environmental factors. Further understanding of miRNA dysregulation and its mechanisms during the development of different autoimmune diseases holds enormous potential to bring about novel therapeutic targets or strategies for these complex human disorders, as well as novel circulating or exosomal miRNA biomarkers.
•miRNAs play crucial roles in regulating both innate and adaptive immune response.•miRNA dysregulation are implicated in the pathogenesis of many autoimmune diseases.•Genetic, epigenetic, and environmental factors affect miRNAs and cause autoimmunity.•miRNAs serve as potential therapeutic targets and biomarkers for autoimmune diseases.•Circulating miRNAs and exosomal miRNAs may be ideal novel biomarkers for SLE and RA.</description><subject>Adaptive immunity</subject><subject>Apoptosis</subject><subject>Autoimmune diseases</subject><subject>Bioindicators</subject><subject>Biomarkers</subject><subject>Biopsy</subject><subject>Chronic conditions</subject><subject>Cyclin-dependent kinases</subject><subject>Dermatomyositis</subject><subject>Dermatomyositis (DM)</subject><subject>Disease</subject><subject>Environmental factors</subject><subject>Epigenetic mechanisms</subject><subject>Fibroblasts</subject><subject>Gene expression</subject><subject>Genomes</subject><subject>Growth factors</subject><subject>Homeostasis</subject><subject>Immune response</subject><subject>Immunity</subject><subject>Inflammation</subject><subject>Kinases</subject><subject>Lupus</subject><subject>Lymphocytes</subject><subject>MicroRNAs</subject><subject>miRNA</subject><subject>Pathogenesis</subject><subject>Post-transcription</subject><subject>Proteins</subject><subject>Rheumatoid arthritis</subject><subject>Rheumatoid arthritis (RA)</subject><subject>RNA polymerase</subject><subject>Scleroderma</subject><subject>Sclerosis</subject><subject>Spatial discrimination</subject><subject>Systemic lupus erythematosus</subject><subject>Systemic lupus erythematosus (SLE)</subject><subject>Systemic sclerosis</subject><subject>Systemic sclerosis (SSc)</subject><subject>Therapeutic applications</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp9kcFu1DAQhi1ERbeFN0DIEhcOJIydOHY4IFWlUKQKEIKz5TiTrZfE3toOUt8eV1t66IGTpdE3M57vJ-Qlg5oB697tamv8jLnmwFQNbV2KT8iGKckr2St4SjbQQFs1qhHH5CSlHQCIVopn5Jj3nQLOmw1ZPt6miNt1NtkFT8NEF2dj-PH1LFHnqVlzcMuyeqSjS2gSpvf0u8nXYYsek0tv6eDCYuJvjIkaP9J9yOizMzPN1xjNHtfsLM0mbjGn5-RoMnPCF_fvKfn16eLn-WV19e3zl_Ozq8q2osuV6HnTq9HICdjArOpHjgqwMYMZWKs6UNDKseuxs3ziQzcIIaWVYgI5sYlPzSl5c5i7j-FmxZT14pLFeTYew5o0h2KgYYr1BX39CN2FNfryu0K1vFM9CFmo9kAVN6kIm_Q-unL2rWag7-LQO32IQ9_FoaHVpVjaXt0PX4cFx4emf_4L8OEAYLHxx2HUyTr0FkcX0WY9Bvf_DX8BQEqebQ</recordid><startdate>20180801</startdate><enddate>20180801</enddate><creator>Long, Hai</creator><creator>Wang, Xin</creator><creator>Chen, Yongjian</creator><creator>Wang, Ling</creator><creator>Zhao, Ming</creator><creator>Lu, Qianjin</creator><general>Elsevier B.V</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20180801</creationdate><title>Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets</title><author>Long, Hai ; Wang, Xin ; Chen, Yongjian ; Wang, Ling ; Zhao, Ming ; Lu, Qianjin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-592398da7f01b1c89d2e80e3abab148608047d69e6c2f2b6b5577c75f07f1f2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adaptive immunity</topic><topic>Apoptosis</topic><topic>Autoimmune diseases</topic><topic>Bioindicators</topic><topic>Biomarkers</topic><topic>Biopsy</topic><topic>Chronic conditions</topic><topic>Cyclin-dependent kinases</topic><topic>Dermatomyositis</topic><topic>Dermatomyositis (DM)</topic><topic>Disease</topic><topic>Environmental factors</topic><topic>Epigenetic mechanisms</topic><topic>Fibroblasts</topic><topic>Gene expression</topic><topic>Genomes</topic><topic>Growth factors</topic><topic>Homeostasis</topic><topic>Immune response</topic><topic>Immunity</topic><topic>Inflammation</topic><topic>Kinases</topic><topic>Lupus</topic><topic>Lymphocytes</topic><topic>MicroRNAs</topic><topic>miRNA</topic><topic>Pathogenesis</topic><topic>Post-transcription</topic><topic>Proteins</topic><topic>Rheumatoid arthritis</topic><topic>Rheumatoid arthritis (RA)</topic><topic>RNA polymerase</topic><topic>Scleroderma</topic><topic>Sclerosis</topic><topic>Spatial discrimination</topic><topic>Systemic lupus erythematosus</topic><topic>Systemic lupus erythematosus (SLE)</topic><topic>Systemic sclerosis</topic><topic>Systemic sclerosis (SSc)</topic><topic>Therapeutic applications</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Long, Hai</creatorcontrib><creatorcontrib>Wang, Xin</creatorcontrib><creatorcontrib>Chen, Yongjian</creatorcontrib><creatorcontrib>Wang, Ling</creatorcontrib><creatorcontrib>Zhao, Ming</creatorcontrib><creatorcontrib>Lu, Qianjin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Long, Hai</au><au>Wang, Xin</au><au>Chen, Yongjian</au><au>Wang, Ling</au><au>Zhao, Ming</au><au>Lu, Qianjin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>2018-08-01</date><risdate>2018</risdate><volume>428</volume><spage>90</spage><epage>103</epage><pages>90-103</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><abstract>MicroRNAs (miRNAs) are small, single-stranded, endogenous non-coding RNAs that repress the expression of target genes via post-transcriptional mechanisms. Due to their broad regulatory effects, the precisely regulated, spatial-specific and temporal-specific expression of miRNAs is fundamentally important to various biological processes including the immune homeostasis and normal function of both innate and adaptive immune response. Aberrance of miRNAs is implicated in the development of various human diseases, especially cancers. Increasing evidence has revealed a dysregulated expression pattern of miRNAs in autoimmune diseases, among which many play key roles in the pathogenesis. In this review we summarize these findings on miRNA dysregulation implicated in autoimmune diseases, focusing on four representative systemic autoimmune diseases, i.e. systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis and dermatomyositis. The causes of the dysregulation of miRNA expression in autoimmune diseases may include genetic and epigenetic variants, and various environmental factors. Further understanding of miRNA dysregulation and its mechanisms during the development of different autoimmune diseases holds enormous potential to bring about novel therapeutic targets or strategies for these complex human disorders, as well as novel circulating or exosomal miRNA biomarkers.
•miRNAs play crucial roles in regulating both innate and adaptive immune response.•miRNA dysregulation are implicated in the pathogenesis of many autoimmune diseases.•Genetic, epigenetic, and environmental factors affect miRNAs and cause autoimmunity.•miRNAs serve as potential therapeutic targets and biomarkers for autoimmune diseases.•Circulating miRNAs and exosomal miRNAs may be ideal novel biomarkers for SLE and RA.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>29680223</pmid><doi>10.1016/j.canlet.2018.04.016</doi><tpages>14</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0304-3835 |
ispartof | Cancer letters, 2018-08, Vol.428, p.90-103 |
issn | 0304-3835 1872-7980 |
language | eng |
recordid | cdi_proquest_miscellaneous_2029631819 |
source | ScienceDirect Freedom Collection |
subjects | Adaptive immunity Apoptosis Autoimmune diseases Bioindicators Biomarkers Biopsy Chronic conditions Cyclin-dependent kinases Dermatomyositis Dermatomyositis (DM) Disease Environmental factors Epigenetic mechanisms Fibroblasts Gene expression Genomes Growth factors Homeostasis Immune response Immunity Inflammation Kinases Lupus Lymphocytes MicroRNAs miRNA Pathogenesis Post-transcription Proteins Rheumatoid arthritis Rheumatoid arthritis (RA) RNA polymerase Scleroderma Sclerosis Spatial discrimination Systemic lupus erythematosus Systemic lupus erythematosus (SLE) Systemic sclerosis Systemic sclerosis (SSc) Therapeutic applications |
title | Dysregulation of microRNAs in autoimmune diseases: Pathogenesis, biomarkers and potential therapeutic targets |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T23%3A05%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dysregulation%20of%20microRNAs%20in%20autoimmune%20diseases:%20Pathogenesis,%20biomarkers%20and%20potential%20therapeutic%20targets&rft.jtitle=Cancer%20letters&rft.au=Long,%20Hai&rft.date=2018-08-01&rft.volume=428&rft.spage=90&rft.epage=103&rft.pages=90-103&rft.issn=0304-3835&rft.eissn=1872-7980&rft_id=info:doi/10.1016/j.canlet.2018.04.016&rft_dat=%3Cproquest_cross%3E2042689057%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c456t-592398da7f01b1c89d2e80e3abab148608047d69e6c2f2b6b5577c75f07f1f2f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2042689057&rft_id=info:pmid/29680223&rfr_iscdi=true |